Exdensur (depemokimab) in two indications, including: As an add-on maintenance treatment for severe asthma with type 2 inflammation, characterized by blood eosinophil count in adults and adolescents ...
A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...
While serious complications from asthma have been on the downswing, the rise of obesity could blunt that progress. Here’s how to help your patients with obesity and asthma.
Dr. Douglas Lotz steps in as Interim CEO, with a clear focus on patient-first care. Building on a legacy of trusted ...
The approval of Exdensur (depemokimab) for severe asthma and chronic rhinosinusitis with nasal polyps by the European ...
By Dennis Thompson HealthDay ReporterMONDAY, Feb. 9, 2026 (HealthDay News) — Children are more likely to develop asthma if they are raised in damp homes or neighborhoods with heavy air pollution, a ...
Inhaled corticosteroids are strongly recommended, in addition to streamlined management with combination and step-up therapy.
The likelihood for asthma and IgE sensitization up to age 24 years was lower among individuals exclusively breastfed for at ...
A new integrated care pathway for paediatric acute asthma enhances inhaler use and key clinical documentation across primary care and ED settings without an increase in admission rates or revisits.
Hormonal shifts may be quietly inflaming your airways.
The primary symptoms of asthma are typically associated with breathing difficulties - here's what you should know ...
A lingering cough is often blamed on asthma or past tuberculosis, but experts warn that a lesser-known fungal lung disease ...